Home > Financial Ratios > BAL PHARMA

BAL PHARMA
EV/Core EBITDA

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 7.298.608.018.728.86

What is the latest EV/Core EBITDA ratio of BAL PHARMA ?

The latest EV/Core EBITDA ratio of BAL PHARMA is 7.29 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar20267.29
Mar20258.60
Mar20248.01
Mar20238.72
Mar20228.86

How is EV/Core EBITDA of BAL PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 7.29
-15.23
Mar2025 8.6
7.37
Mar2024 8.01
-8.14
Mar2023 8.72
-1.58
Mar2022 8.86 -

Other Financial Ratios of BAL PHARMA


Compare EV/Core EBITDA ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹159.4 Cr -6.7% 17.8% 15.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-6.7%

17.8%

15.3%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses